May 3, 2024 — Reports of first quarter business results from Novo Nordisk and Eli Lilly this week leave no room for doubt. The utilization of obesity treatment is growing at a rate that has caught both of these companies by surprise. Wegovy sales more than doubled in the first quarter of 2024. On top of that, new prescriptions […]
April 19, 2024 — Perhaps it was inevitable. Last week, the Times plunged into stereotypes about obesity care and gender, asking “Is the era of ‘Brozempic’ upon us?” The spark for the story comes from the efforts of telehealth businesses trying to crack the code for reaching men with concerns about obesity. It can be awkward. The cultural baggage […]
January 5, 2024 — Eli Lilly and Company has taken the unusual step of starting a direct to consumer clinical care and pharmacy program for obesity, diabetes, and migraine. If you have any doubt that LillyDirect will shake up the landscape for access to obesity care, just ask the folks at WeightWatchers. Their stock dropped by 11% yesterday when […]
January 2, 2024 — The year we just finished saw quite a pivot in the science and policy we cover here. So what will we pivot toward in 2024? What will leave us cold? Here are our best educated guesses for what will be hot or not in 2024 for obesity and health. #1 Hot: Pricing Drug prices will […]
May 28, 2023 — “Money makes the world go around.” Joel Grey and Liza Minnelli explained this in Cabaret. But sorting it out in healthcare – and specifically in obesity care right now – is quite a challenge. A lot of money is in play and so the tension between greed, health, and obesity care is painfully obvious. The […]
March 7, 2023 — Okay, we’re awake now. WeightWatchers has entered a deal to add telehealth and obesity meds to their business strategy. The company will spend $132 million in cash and stock to acquire Sequence – a subscription telehealth service for weight loss that utilizes advanced obesity meds like semaglutide. Weight Watchers CEO Sima Sistani explains her rationale […]
August 10, 2022 — Before the COVID-19 pandemic, we could find lots of talk about the potential of telehealth – and see its potential for extending the reach of obesity care. Translation into action and care delivery, though, was very slow. When the pandemic became a constraint for face to face care delivery, that changed overnight. Telehealth care for […]
January 19, 2022 — A new study in Obesity tells us that telehealth can work just fine in obesity care. But what will the future hold? Payers and patients will likely have their their say. Already, telehealth businesses have had quite a bumpy ride. A prime example would be Teledoc, which saw its stock soar from $83 per share […]
December 17, 2021 — We can’t believe it either. This weird, messy year is winding down and it’s time to figure out what just happened as we prepare to go into an new year of promise and uncertainty. In obesity and health, 2021 was full of change, confusion, and new insights. We started the year with a raging pandemic, […]
November 6, 2021 — It’s all over – except for the replays and reviews. ObesityWeek® 2021 wrapped up yesterday and with any luck (we’re looking at you, COVID) this will be the last purely online week of obesity research, policy, and practice for a while. Next year, the plan is for a hybrid meeting. So now it’s time to […]
